logo
Select company
Select metric
$ -22.22MConsolidated Income
VS
Market
27
Sector
53
Industry
67
History
88
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -22.22M
3/31/2025$ -28.23M
12/31/2024$ -29.67M
9/30/2024$ -23.86M
6/30/2024$ -24.61M
3/31/2024$ -21.67M
12/31/2023$ -21.43M
9/30/2023$ -19.28M
6/30/2023$ -39.06M
3/31/2023$ -73.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -122.54M.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average Cons. Inc. has been $ -61.12M.
  • The median Cons. Inc. for Y-MABS THERAPEUTICS INC during this period was $ -40.67M
  • Y-MABS THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -19.28M.
  • The lowest Cons. Inc. recorded by Y-MABS THERAPEUTICS INC in the same timeframe $ -134.95M

Y-MABS THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ADCT : ADC THERAPEUTICS SA $ -169.94MNKTR : NEKTAR THERAPEUTICS $ -122.27MKURA : KURA ONCOLOGY INC $ -197.17MLXRX : LEXICON PHARMACEUTICALS INC $ -120.62MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MXOMA : XOMA ROYALTY CORP $ -9.65MSAGE : SAGE THERAPEUTICS INC $ -301.19MCDXS : CODEXIS INC $ -64.98MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -60.16MSGMO : SANGAMO THERAPEUTICS INC $ -63.31M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

YMAB - Consolidated Income, Last 5 years

$ -134.95M

Minimum

Jun 30, 2022

$ -19.28M

Maximum

Sep 30, 2023

$ -61.12M

Average

$ -40.67M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M